within Pharmacolibrary.Drugs.ATC.D;

model D01AC14
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D01AC14</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sertaconazole is an imidazole antifungal agent primarily used topically for the treatment of dermatophytosis (such as tinea pedis) and cutaneous candidiasis. It acts by inhibiting ergosterol synthesis in fungal cell membranes. Sertaconazole is approved for topical use in several countries but is not approved for systemic use due to minimal absorption.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for topical administration in healthy adult subjects. Sertaconazole exhibits minimal systemic absorption after topical administration.</p><h4>References</h4><ol><li><p>Carrillo-Muñoz, AJ, et al., &amp; Quindós, G (2013). Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis. <i>Expert review of anti-infective therapy</i> 11(4) 347–358. DOI:<a href=\"https://doi.org/10.1586/eri.13.17\">10.1586/eri.13.17</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23566144/\">https://pubmed.ncbi.nlm.nih.gov/23566144</a></p></li><li><p>Susilo, R, et al., &amp; Menke, A (2005). Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration. <i>Arzneimittel-Forschung</i> 55(6) 338–342. DOI:<a href=\"https://doi.org/10.1055/s-0031-1296869\">10.1055/s-0031-1296869</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16032974/\">https://pubmed.ncbi.nlm.nih.gov/16032974</a></p></li><li><p>Sahoo, S, et al., &amp; Sahoo, SK (2016). Effect of microemulsion in topical sertaconazole hydrogel: in vitro and in vivo study. <i>Drug delivery</i> 23(1) 338–345. DOI:<a href=\"https://doi.org/10.3109/10717544.2014.914601\">10.3109/10717544.2014.914601</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24845480/\">https://pubmed.ncbi.nlm.nih.gov/24845480</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D01AC14;
